the methods comprise the step of administering to the patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength (a "therapeutic amount")
Kbler, The utilization of intravenously infused pyridoxine in humans, Clin
first, through the oxidation of cysteine to form cysteine sulfonic acid (CSA) by the mitochondrial enzyme cysteine dioxygenase (CDO), followed by the decarboxylation to hypotaurine by cysteine sulfonic acid decarboxylase (CSAD) and an oxidation to taurine by the flavin-containing monooxygenase (FMO) enzyme [90]
Gastrointestinal health: Protects against gastric ulcers, inflammatory bowel disease, and damage from NSAIDs or alcohol Systemic effect: Because of its stability and signaling capacity, oral BPC-157 may also support systemic healing in joints, tendons, and nerves